Dorsey Wright & Associates purchased a new position in shares of Anthem, Inc. (NYSE:ANTM) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 8,884 shares of the company’s stock, valued at approximately $1,687,000.
A number of other large investors have also modified their holdings of ANTM. C M Bidwell & Associates Ltd. increased its stake in shares of Anthem by 0.5% during the second quarter. C M Bidwell & Associates Ltd. now owns 1,070 shares of the company’s stock worth $201,000 after buying an additional 5 shares during the period. Salem Investment Counselors Inc. increased its stake in shares of Anthem by 1.4% during the second quarter. Salem Investment Counselors Inc. now owns 710 shares of the company’s stock worth $134,000 after buying an additional 10 shares during the period. Cedar Wealth Management LLC increased its stake in shares of Anthem by 1.7% during the second quarter. Cedar Wealth Management LLC now owns 908 shares of the company’s stock worth $171,000 after buying an additional 15 shares during the period. Gofen & Glossberg LLC IL increased its stake in shares of Anthem by 0.6% during the second quarter. Gofen & Glossberg LLC IL now owns 2,540 shares of the company’s stock worth $478,000 after buying an additional 15 shares during the period. Finally, Dowling & Yahnke LLC increased its stake in shares of Anthem by 0.3% during the second quarter. Dowling & Yahnke LLC now owns 7,175 shares of the company’s stock worth $1,350,000 after buying an additional 18 shares during the period. Institutional investors own 88.91% of the company’s stock.
Shares of Anthem, Inc. (NYSE ANTM) traded up $0.19 during midday trading on Tuesday, hitting $218.46. The company had a trading volume of 2,432,900 shares, compared to its average volume of 1,593,805. The company has a current ratio of 1.51, a quick ratio of 1.51 and a debt-to-equity ratio of 0.53. Anthem, Inc. has a 52-week low of $132.65 and a 52-week high of $220.75. The firm has a market capitalization of $56,043.11, a P/E ratio of 17.52, a PEG ratio of 1.71 and a beta of 0.77.
Anthem (NYSE:ANTM) last issued its quarterly earnings results on Wednesday, October 25th. The company reported $2.65 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.40 by $0.25. Anthem had a return on equity of 12.97% and a net margin of 3.35%. The firm had revenue of $22.10 billion during the quarter, compared to the consensus estimate of $22.10 billion. During the same period last year, the company earned $2.45 earnings per share. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. research analysts expect that Anthem, Inc. will post 11.97 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 21st. Investors of record on Tuesday, December 5th will be issued a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 1.28%. The ex-dividend date is Monday, December 4th. Anthem’s dividend payout ratio is presently 25.32%.
In related news, insider Joseph Swedish sold 21,125 shares of the stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $190.63, for a total transaction of $4,027,058.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Ronald W. Penczek sold 978 shares of the stock in a transaction on Tuesday, November 7th. The stock was sold at an average price of $217.42, for a total value of $212,636.76. Following the sale, the senior vice president now directly owns 1,222 shares of the company’s stock, valued at $265,687.24. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 65,955 shares of company stock valued at $13,179,953. Corporate insiders own 0.36% of the company’s stock.
A number of brokerages recently issued reports on ANTM. Zacks Investment Research downgraded Anthem from a “buy” rating to a “hold” rating in a report on Wednesday, August 30th. BidaskClub raised Anthem from a “hold” rating to a “buy” rating in a report on Thursday, October 26th. Morgan Stanley upped their price target on Anthem from $201.00 to $215.00 and gave the company an “equal weight” rating in a report on Thursday, October 26th. Jefferies Group LLC upped their price target on Anthem from $204.00 to $211.00 and gave the company a “hold” rating in a report on Friday, October 13th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $215.00 price target on shares of Anthem in a report on Wednesday, September 20th. Eight research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $197.69.
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTM).
Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.